europe-glucose-monitoring-devices-market-industry
Published

November 2016

Europe Glucose Monitoring Devices Market - Industry Analysis and Market Forecast 2016-2021

Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license

Europe’s glucose monitoring device market is forecasted to reach USD 5.78 billion by 2021 at a CAGR of 9.44 %.

Europe’s Glucose Monitoring Devices Market- Market Dynamics

The direct and indirect costs of diabetes care are increasing with the rise in the prevalence of various complications due to the disease. In the European Union, about £93 billion were lost due to these direct and indirect costs linked to diabetes. This increased spending is putting pressure on governments to take the steps essential to keep the disease in check and avoid complications in order to ensure that these losses are kept to a minimum. This is expected to help boost the sales of blood glucose meters, as keeping a check on blood glucose will help patients in managing their diabetes, thereby reducing the risk of developing complications.

Drivers

Some of the factors driving the growth of the glucose monitoring devices in Europe are:

  • Increasing technological innovations in diagnosis and monitoring of diabetes
  • Increasing incidence of people suffering from diabetes
  • Early detection of hypo and hyperglycemic diabetes
  • Increased demand for continuous glucose monitoring
  • Increased demand for faster, safer and effective glucose monitoring

Restraints

While there is ample scope for growth in the glucose monitoring devices market in Europe, there are some factors restraining it. These include:

  • High cost associated with diagnosis and treatment
  • Reimbursement issues
  • Patent expiry

Europe Glucose monitoring device market is segmented into blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring device and by geography into France, Italy, UK, Spain, and Germany.

Some of the key players in the market are:

  • Accruex Biomedical Pvt. Ltd.
  • Apex Biotechnology Corp.
  • DexCom, Inc.
  • F. Hoffmann-La Roche AG
  • LifeScan, Inc.
  • Teco Diagnostics

What the Report Offers

  • Market definition for Europe’s glucose monitoring devices market with information on drivers and restraints.
  • Market Analysis involving glucose monitoring devices like blood glucose meters, blood glucose strips, lancets etc.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape with profiles of major companies along with their market share.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • In-depth market segmentation by glucose monitoring devices (blood glucose meters, blood glucose testing strips, lancets, and continuous glucose monitoring device).
  • Comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
  • Wide-ranging information provided about the leading market players, major strategies adopted by them and new products launched by them.
RELATED REPORTS
No related reports available.
Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license
Our Clients Include View All

Looking to Customize Report?